Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Kempharm Inc

(NASDAQ: KMPH)
Add to Portfolio
+0.16 (+11.19%)
as of Jun 14, 2019

Last 1.59
Change +0.16 (+11.19%)
Open 1.50
Prev. Close 1.43
Today's Range
1.50
1.59
52wk Range
1.15
6.85
Volume 95,300
Avg Volume 111,330
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
KMPH +11.19% -12.64% -74.56%
DJIA -0.07% -0.49% +3.63%
S&P 500 -0.16% +0.47% +3.76%

Key Statistics

Annual EPS -2.51
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 41,920
Weighted Alpha -62.50
Standard Deviation +2.24
Profit Margin N/A
Beta 1.40

Growth Rates

YTD -10.67%
1-Year -73.28%
3-Year -63.02%

Opinion

Sell Hold Buy

Recent Headlines

KemPharm to Present at Upcoming Investor Conferences

GlobeNewswire via COMTEX - Tue Mar 05, 07:29AM EST
KemPharm, Inc. (Nasdaq:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced that management will present at several investor conferences during March 2019.(full story)
KMPH: 1.59 (+0.16)

KemPharm to Report Fourth Quarter and Year End 2018

GlobeNewswire via COMTEX - Thu Feb 21, 04:15PM EST
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Thursday, February 28, 2019, 4:30 p.m. ET(full story)
KMPH: 1.59 (+0.16)

KemPharm Announces Enhancements to U.S. and Global

GlobeNewswire via COMTEX - Tue Jan 29, 07:29AM EST
Patents Extend Across KemPharm's Prodrug Portfolio, Including IP Protection for KP415 in Canada, Japan and Korea(full story)
KMPH: 1.59 (+0.16)